American Century Companies’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$642K Buy
33,470
+710
+2% +$15.4K ﹤0.01% 2458
2025
Q4
$720K Buy
32,760
+11
+0% +$199 ﹤0.01% 2415
2025
Q3
$398K Buy
+32,749
New +$443K ﹤0.01% 2569
2023
Q2
Sell
-12,391
Closed -$503K 2842
2023
Q1
$503K Buy
12,391
+732
+6% +$30.3K ﹤0.01% 2126
2022
Q4
$524K Buy
+11,659
New +$528K ﹤0.01% 2035
2022
Q3
Sell
-428,340
Closed -$25.4M 2473
2022
Q2
$25.4M Buy
428,340
+95,841
+29% +$7.87M 0.02% 598
2022
Q1
$38.7M Buy
332,499
+68,811
+26% +$8.03M 0.03% 512
2021
Q4
$39.7M Buy
263,688
+47,473
+22% +$6.41M 0.03% 529
2021
Q3
$25.8M Sell
216,215
-137,830
-39% -$15.2M 0.02% 625
2021
Q2
$34.5M Sell
354,045
-67,710
-16% -$6.04M 0.02% 542
2021
Q1
$37.2M Sell
421,755
-259,495
-38% -$24.1M 0.03% 500
2020
Q4
$65.2M Buy
681,250
+19,034
+3% +$1.96M 0.05% 345
2020
Q3
$75.2M Sell
662,216
-31,284
-5% -$3.29M 0.07% 288
2020
Q2
$68.6M Sell
693,500
-54,112
-7% -$4.32M 0.07% 281
2020
Q1
$48.1M Buy
747,612
+239,901
+47% +$16.8M 0.06% 307
2019
Q4
$30.3M Buy
507,711
+45,972
+10% +$2.84M 0.03% 438
2019
Q3
$27.2M Buy
+461,739
New +$29.5M 0.03% 436
2016
Q3
Sell
-24,622
Closed -$1.86M 1410
2016
Q2
$1.86M Buy
24,622
+248
+1% +$20K ﹤0.01% 1042
2016
Q1
$2.12M Buy
+24,374
New +$2.13M ﹤0.01% 986

Other funds holding TNDM

American Century Companies's TNDM Position: Q1 2026 in Review

American Century Companies increased its Tandem Diabetes Care (TNDM) stake by 2.2% in Q1 2026, buying an estimated $15.4K and bringing the position to 33,470 shares worth $642K. The position accounts for ﹤0.01% of the portfolio, ranked #2458.

American Century Companies first reported a position in TNDM in Q1 2016 and has held it in 19 quarters since. The position peaked at $75.2M in Q3 2020. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • American Century Companies held 33,470 shares of Tandem Diabetes Care worth $642K as of Q1 2026.
  • American Century Companies bought 710 Tandem Diabetes Care shares in Q1 2026, an estimated $15.4K.
  • Tandem Diabetes Care made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2458 holding.
  • American Century Companies first reported a position in Tandem Diabetes Care in Q1 2016 and has held it in 19 quarters since.
  • American Century Companies's Tandem Diabetes Care position peaked at $75.2M in Q3 2020.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.